Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 2000 Nov;90(11):1778–1781. doi: 10.2105/ajph.90.11.1778

Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome.

B Khoshnood 1, P Pryde 1, S Wall 1, J Singh 1, R Mittendorf 1, K S Lee 1
PMCID: PMC1446403  PMID: 11076250

Abstract

OBJECTIVES: This study explored whether ethnic differences in the impact of advanced maternal age on the risk of Down syndrome might reflect differences in use of prenatal diagnostic technologies. METHODS: Maternal age-specific odds of Down syndrome and amniocentesis use were compared among African Americans, Mexican Americans, and non-Hispanic Whites via birth data for the years 1989 to 1991. RESULTS: The odds ratio and population attributable risk of Down syndrome due to maternal age of 35 years or older were highest for Mexican Americans, intermediate for African Americans, and lowest for non-Hispanic Whites. CONCLUSIONS: Advanced maternal age has a greater impact on the risk of Down syndrome for African American and, particularly, Mexican American women than for non-Hispanic White women. This difference in impact might reflect lower availability or use of prenatal diagnostic technologies.

Full Text

The Full Text of this article is available as a PDF (77.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird P. A., Sadovnick A. D. Maternal age-specific rates for Down syndrome: changes over time. Am J Med Genet. 1988 Apr;29(4):917–927. doi: 10.1002/ajmg.1320290424. [DOI] [PubMed] [Google Scholar]
  2. Bell J. A. The epidemiology of Down's syndrome. Med J Aust. 1991 Jul 15;155(2):115–117. doi: 10.5694/j.1326-5377.1991.tb142143.x. [DOI] [PubMed] [Google Scholar]
  3. Benacerraf B. R. The second-trimester fetus with Down syndrome: detection using sonographic features. Ultrasound Obstet Gynecol. 1996 Feb;7(2):147–155. doi: 10.1046/j.1469-0705.1996.07020147.x. [DOI] [PubMed] [Google Scholar]
  4. Benn P. A., Clive J. M., Collins R. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Clin Chem. 1997 Feb;43(2):333–337. [PubMed] [Google Scholar]
  5. Bishop J., Huether C. A., Torfs C., Lorey F., Deddens J. Epidemiologic study of Down syndrome in a racially diverse California population, 1989-1991. Am J Epidemiol. 1997 Jan 15;145(2):134–147. doi: 10.1093/oxfordjournals.aje.a009084. [DOI] [PubMed] [Google Scholar]
  6. Greenland S., Robins J. M. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol. 1988 Dec;128(6):1185–1197. doi: 10.1093/oxfordjournals.aje.a115073. [DOI] [PubMed] [Google Scholar]
  7. Haddow J. E., Palomaki G. E., Knight G. J., Williams J., Pulkkinen A., Canick J. A., Saller D. N., Jr, Bowers G. B. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med. 1992 Aug 27;327(9):588–593. doi: 10.1056/NEJM199208273270902. [DOI] [PubMed] [Google Scholar]
  8. Krivchenia E., Huether C. A., Edmonds L. D., May D. S., Guckenberger S. Comparative epidemiology of Down syndrome in two United States population, 1970-1989. Am J Epidemiol. 1993 Apr 15;137(8):815–828. doi: 10.1093/oxfordjournals.aje.a116743. [DOI] [PubMed] [Google Scholar]
  9. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  10. O'Brien J. E., Dvorin E., Drugan A., Johnson M. P., Yaron Y., Evans M. I. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. Obstet Gynecol. 1997 Mar;89(3):355–358. doi: 10.1016/S0029-7844(96)00524-8. [DOI] [PubMed] [Google Scholar]
  11. Pryde P. G., Drugan A., Johnson M. P., Isada N. B., Evans M. I. Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results. Clin Obstet Gynecol. 1993 Sep;36(3):496–509. doi: 10.1097/00003081-199309000-00008. [DOI] [PubMed] [Google Scholar]
  12. Sokal D. C., Byrd J. R., Chen A. T., Goldberg M. F., Oakley G. P., Jr Prenatal chromosomal diagnosis. Racial and geographic variation for older women in Georgia. JAMA. 1980 Sep 19;244(12):1355–1357. doi: 10.1001/jama.244.12.1355. [DOI] [PubMed] [Google Scholar]
  13. Taipale P., Hiilesmaa V., Salonen R., Ylöstalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med. 1997 Dec 4;337(23):1654–1658. doi: 10.1056/NEJM199712043372303. [DOI] [PubMed] [Google Scholar]
  14. Ventura S. J. Trends and variations in first births to older women, United States, 1970-86. Vital Health Stat 21. 1989 Jun;(47):1–27. [PubMed] [Google Scholar]
  15. Verp M. S., Bombard A. T., Simpson J. L., Elias S. Parental decision following prenatal diagnosis of fetal chromosome abnormality. Am J Med Genet. 1988 Mar;29(3):613–622. doi: 10.1002/ajmg.1320290320. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES